focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,783.50
Bid: 1,780.00
Ask: 1,780.50
Change: -29.00 (-1.60%)
Spread: 0.50 (0.028%)
Open: 1,792.50
High: 1,802.00
Low: 1,775.50
Prev. Close: 1,812.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK fraud head expects corporate plea deals, considers Libor charges

Tue, 25th Oct 2016 14:53

* SFO head David Green gives evidence to UK lawmakers

* Green says "significant" new DPAs on horizon

* Green says Serco probe looking at "different conduct"

By Kirstin Ridley

LONDON, Oct 25 (Reuters) - The UK Serious Fraud Office (SFO)expects to agree some "significant" corporate plea deals overthe coming months and is also considering filing more charges inthe Libor benchmark rate rigging investigation, its head said onTuesday.

The SFO's probe into alleged manipulation of benchmark ratessuch as Libor (London interbank offered rate), which began in2012, has so far resulted in five convictions and six acquittalsof individuals. Eight others face trial next year.

SFO director David Green told a parliamentary committee oflawmakers that there were also "some others" who it had todecide whether to charge.

Lawmakers asked whether the SFO had the resources to providea credible threat of prosecution if companies failed to reportthemselves to the authorities when they discover wrongdoing.

Green said he had spent four years speaking at leastfortnightly with businesses and lawyers explaining theincentives behind self-reporting, while building up the agency'sintelligence division.

"You will see over the coming months some significantdeferred prosecution agreements (DPAs)," he said.

DPAs, effective plea deals introduced in Britain in 2014,were a useful tool to encourage good corporate conduct, Greensaid, and were available to those who report wrongdoingpromptly, cooperate, grant authorities access to factualdocuments and assist in prosecuting individuals.

A judge approved Britain's first DPA in November in a casecentred on $6 million in bribes paid to Tanzanian officials bythe Tanzanian unit of South Africa's Standard Bank.

Tesco is among companies cooperating with acriminal inquiry into accounting practices, launched after thesupermarket chain said it overstated half year profits in August2014 by about 260 million pounds ($320 million).

Green also said a new line of inquiry had also been openedin a three-year inquiry into global outsourcing group Serco, launched after an audit alleged the government had beencharged for tagging criminals who were either dead or in prison.

The SFO head gave no further details on the Libor inquiry, aglobal investigation in which it has charged around 20.

Barclays, which has seen 10 former traders chargedfor alleged benchmark rigging and admitted in 2012 tolow-balling, or artificially lowering, rates during the creditcrisis, reiterated in its 2015 annual report that it continuedto respond to information requests as part of an SFO inquiry. (Editing by Alexander Smith)

More News
29 Dec 2023 13:01

LONDON MARKET CLOSE: UK equities outclassed by other markets in 2023

(Alliance News) - Stock prices in London closed mixed on Friday, the final trading day of 2023, as the annual returns from UK equities were outshone by international markets.

Read more
20 Dec 2023 13:29

GSK buys rights to Hansoh Pharma antibody-drug conjugate

(Sharecast News) - GSK has agreed to buy the rights to an antibody-drug conjugate (ADC) - HS-20093 - from Chinese biopharmaceutical group Hansoh Pharma.

Read more
19 Dec 2023 15:36

German court quashes CureVac patent after challenge by BioNTech

CureVac shares drop 40%Dispute over intellectual property with BioNTech to continue

*

Read more
18 Dec 2023 17:21

Energy stocks lift UK's FTSE 100, Vodafone shines

Vodafone jumps as Iliad offers to merge Italian units

*

Read more
18 Dec 2023 10:07

GSK's dostarlimab trial in endometrial cancer meets primary endpoint

(Alliance News) - GSK PLC on Monday said a trial of dostarlimab in combination with niraparib for treating endometrial cancer has met its primary endpoint.

Read more
18 Dec 2023 07:55

LONDON BRIEFING: Games Workshop seals Amazon deal for Warhammer 40,000

(Alliance News) - Stocks in London were set to retreat slightly on Monday, in line with equity markets in Asia, at the start of the last week before the Christmas holidays.

Read more
18 Dec 2023 07:18

GSK sees success in Jemperli endometrial cancer trial

(Sharecast News) - GSK released positive headline results from the planned analysis of its trial of Jemperli in endometrial cancer on Monday.

Read more
17 Dec 2023 15:16

PRESS: GSK looks for deals in China as rebuilds relationship

(Alliance News) - The Financial Times on Sunday reported that GSK PLC is looking for some new deals in China.

Read more
15 Dec 2023 17:08

European shares end fifth week higher on rate-cut optimism

Barclays sees first ECB rate cut in April

*

Read more
15 Dec 2023 16:51

LONDON MARKET CLOSE: FTSE 100 underperforms as post-Fed rally cools

(Alliance News) - London's FTSE 100 ended lower on Friday, with profit-taking and some hawkish words from a US policymaker keeping equities in check at the end of a largely positive week for stocks.

Read more
15 Dec 2023 16:29

PRESS: GSK, Astra and AbbVie in US scrutiny over patents - Bloomberg

(Alliance News) - A US senator has accused AstraZeneca PLC, GSK PLC, AbbVie Inc and other drugmakers of "abusing" the patent system to send prices higher, Bloomberg reported on Thursday.

Read more
12 Dec 2023 10:08

AstraZeneca buys respiratory vaccine developer Icosavax in $1.1 bln deal

Dec 12 (Reuters) - AstraZeneca said on Tuesday it had agreed to buy respiratory syncytial virus (RSV) vaccine developer Icosavax in a deal valued at up to $1.1 billion.

Read more
12 Dec 2023 08:22

TOP NEWS: Japan accepts GSK's filing for respiratory disease vaccine

(Alliance News) - GSK PLC on Tuesday said Japan's Ministry of Health, Labour & Welfare has accepted its regulatory application for the extension of its respiratory syncytial virus vaccine, Arexvy, for adults aged 50-59.

Read more
12 Dec 2023 07:39

LONDON BRIEFING: UK unemployment unchanged at 4.2%; eyes on US CPI

(Alliance News) - Stocks in London are called to open higher, as investors digest the latest UK unemployment data, before turning their heads to US inflation.

Read more
12 Dec 2023 07:24

GSK seeks to extend RSV vaccine approval in Japan

(Sharecast News) - GSK announced on Tuesday that Japan's Ministry of Health, Labour and Welfare (MHLW) has accepted its regulatory application for the extension of the indication of its RSV vaccine to include adults aged 50- to 59 at an increased risk of contracting the disease.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.